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Abstract.  CENP-E is a kinesin-like protein that binds 
to kinetochores through the early stages of mitosis, 
but after initiation  of anaphase,  it relocalizes to the 
overlapping microtubules in the midzone, ultimately 
concentrating  in the developing midbody. By immuno- 
blotting of cells separated at various positions in the 
cell cycle using centrifugal elutriation,  we show that 
CENP-E levels increase progressively across the cycle 
peaking at ~22,000 molecules/cell early in mitosis, 
followed by an abrupt (>10 fold) loss at the end of mi- 
tosis.  Pulse-labeling with [35S]methionine  reveals that 
beyond a twofold increase in synthesis between G1 and 
G2,  interphase accumulation results primarily from 
stabilization of CENP-E during  S and G2.  Despite 
localizing in the midbody during normal cell division, 
CENP-E loss at the end of mitosis is independent of 
cytokinesis, since complete blockage of division with 
cytochalasin has no affect on CENP-E loss at the 
M/G1 transition.  Thus,  like mitotic cyclins, CENP-E 
accumulation peaks before cell division,  and it is 
specifically degraded at the end of mitosis.  However, 
CENP-E degradation kinetically follows proteolysis of 
cyclin B in anaphase.  Combined with cyclin A de- 
struction before the end of metaphase,  degradation 
of as yet unidentified components at the metaphase/ 
anaphase transition,  and cyclin B degradation at or af- 
ter the anaphase transition,  CENP-E destruction 
defines a fourth point in a mitotic cascade of timed 
proteolysis. 
URIN6 mitosis, mammalian cells undertake a complex 
series of steps that ultimately  result in the segrega- 
tion of chromosomes. The start of mitosis, termed 
prophase,  is marked by initiation of chromosome condensa- 
tion.  At prometaphase, condensation is largely  completed, 
and the nuclear envelope disintegrates.  Coordinately,  the cy- 
toplasmic  microtubule  array  is  disassembled  and  astral 
microtubules appear at the separated mitotic poles (centro- 
somes). Chromosome movements are mediated by microtu- 
bules (e.g., Gorbsky et al., 1987; Koshland et al., 1988) that 
extend from the centrosomes to a specialized  region of the 
chromosome referred to as the kinetochore (Euteneur and 
Mclntosh,  1981). In fact, kinetochores have been shown in 
vitro to capture microtubules that originate from the spindle 
poles  (Mitchison  and  Kirschner,  1985).  The  role  of the 
kinetochore is not a static one, however, since in vivo efforts 
have shown it to participate  actively  in poleward  chromo- 
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some  movement  (Nicklas,  1989;  Reider  and  Alexander, 
1990). Moreover, in vitro experiments  (Hyman and Mitchi- 
son, 1991) have shown that isolated chromosomes can trans- 
locate along microtubules in either direction depending  on 
ATP concentration  and  inhibition  of phosphatases.  These 
observations have lead to the view that the kinetochore plays 
an active role in chromosomal segregation  during  mitosis. 
Only a handful  of mammalian  kinetochore antigens have 
been identified to date.  One of these,  CENP-E, colocalizes 
with the centromere/kinetochore during metaphase, but re- 
leases from the centromere at,  or just after,  the onset of 
anaphase, relocalizing to the midbody during telophase (Yen 
et al.,  1991). cDNA cloning  of CENP-E has revealed  the 
312-kD CENP-E polypeptide to consist of a tripartite  struc- 
ture comprised of amino- and carboxy-terminal  globular do- 
mains separated by a 1,500-residue  u-helical domain that is 
predicted to form coiled-coils (Yen et al.,  1992). Addition- 
ally, the amino-terminal  domain of CENP-E contains strik- 
ing homology to the microtubule-dependent motor protein 
kinesin,  demonstrating  CENP-E  to  be a  member of the 
growing  family of kinesin-like  proteins (for review see En- 
dow, 1991; Skoufias and Scholey,  1993). 
Beyond  the  potential  that  CENP-E  may  function  as  a 
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in CENP-E also arose from its cell cycle-dependent accumu- 
lation and loss. First suggested by the failure of immunofluo- 
rescence methods to detect CENP-E in most interphase cells 
(Yen et al.,  1991), immunoprecipitations of CENP-E from 
extracts of drug-synchronized HeLa ceils at different stages 
of the cell cycle confirmed that CENP-E levels were low in 
G1 cell extratcs but increased in amount in extracts derived 
from S and G2/M cell populations.  Furthermore, a qualitative 
pulse-chase experiment determined that CENP-E was lost as 
cells transitioned from M phase to G1  (Yen et al.,  1992). 
The best understood group of proteins whose abundance 
changes markedly under cell cycle control are the mitotic cy- 
clins A and B. In particular, cyclin B has been shown to peak 
in abundance before mitosis, but then is nearly quantitatively 
(~20-fold) lost at the completion of cell division (Evans et 
al.,  1983;  Standart et al.,  1987; Pines and Hunter,  1989; 
Westendorf et al., 1989, Hunt et al., 1992). The association 
of cyclin with the kinase p34  cDc2 is one of the necessary 
steps in the formation of maturation promotion factor, a mi- 
totically active kinase complex whose activity is responsible 
for the transition of interphase cells into mitosis (for review 
see  Murray  and  Kirschner,  1989a;  Norbury  and  Nurse, 
1992). The importance of cyclin accumulation and degrada- 
tion in the control of M-phase initiation and completion is 
underscored by the observations that the accumulation of cy- 
clins is required for cellular entry into mitosis (Swenson et 
al.,  1986;  Minshull et al.,  1989a;  Murray and Kirschner, 
1989b) and cyclin mutants that cannot be degraded after the 
onset of mitosis cause cell cycle arrest in mitosis (Murray 
et al., 1989; Luca et al., 1991; Gallant and Nigg, 1992; van 
der Velden and Lohka, 1993). While it is now clear that the 
degradation of cyclin B is not responsible for triggering the 
metaphase to anaphase transition (Surana et al., 1993; Hol- 
loway et al., 1993), as had long been assumed (e.g., Murray 
and Kirschner, 1989a), it seems inescapable that control of 
cyclin levels  serves an important role in the regulation of 
maturation promotion factor activity. 
Following what is  known for mitotic cyclins, we  now 
investigate the mechanism(s) responsible for CENP-E ac- 
cumulation and loss throughout the cell cycle.  A  combi- 
nation  of approaches  reveal  that  CENP-E  is  synthesized 
steadily, but the major contributor to accumulation is stabili- 
zation of the polypeptide during S and G2 phases of the cell 
cycle and rapid, specific degradation at the end of mitosis. 
The degradation of CENP-E temporally follows that of  cyclin 
B, establishing a temporal cascade of proteolysis during mi- 
tosis beginning with cyclin A at or before metaphase, one or 
more unknown proteins at the metaphase/anaphase transi- 
tion, cyclin B during or after the metaphase/anaphase transi- 
tion, and CENP-E later in anaphase/telophase. 
Materials and Methods 
Cell Culture and Synchronization 
HeLa cells were cultured in DME supplemented with 10% FCS. K562 cells 
were grown in spinner flasks in RPMI 1640 supplemented with 10% calf 
serum. Both cell lines were maintained at 37°C in a humidified 5% CO: 
atmosphere. The insect cell line (St9 cells) that was used for baculovirus 
expression was maintained at room temperature in Grate's modified insect 
media supplemented with 10%  heat-inactivated FCS. 
For centrifugal elutriations, K562 cells were grown to a density of 1-3 
×  105 cells/ml. Typically,  "~3  x  l0  s cells were used in each elutriation. 
Cells were elutriated into 100-ml fractions using a counterflow centrifugal 
elutriator (JE-63; Beckman Instruments, Inc., Fullerton, CA) according to 
established protocols (Kauffman et al., 1990).  Cell cycle phases were deter- 
mined by  flow cytometry using  ethidium bromide (Sherley and  Kelly, 
1988). 
To obtain K562 cells blocked in the G1/S portion of the cell cycle, a 
double-thymidine block was used. Briefly, thymidine (2 mM final concen- 
tration) was added to cultures of cells in exponential growth phase, and the 
cells were incubated for 24 h. After this period, the cells were harvested 
by centrifugation, rinsed in thymidine-free complete media, and incubated 
for an additional 12 h. Subsequently, thymidine was again added to the cul- 
ture media, and the cells were incubated in this state for an additional 24 h. 
At the conclusion of this final incubation, flow cytometry analysis deter- 
mined that >90%  of the cell population were synchronized at G1/S. 
Mitotic shake off was used for isolation of mitotic HeLa cells. Initially, 
flasks of HeLa cells in log phase growth were firmly shaken to remove the 
loosely adherent mitotic cells. Subsequently, the media was decanted, and 
the cells were harvested by centrifugation (direct observation revealed that 
>95 % of the cells were in mitosis). To obtain cells in early GI, mitotic cells 
were replated in prewarmed, complete media and incubated for 3 h, after 
which >97%  of the ceils were in  interphase, as determined by phase- 
contrast microscopy. Cells blocked in pmmetaphase were obtained by add- 
ing 0.1 #g/ml of nocodazole (prepared as a 1 mg/ml stock solution in etha- 
nol) to cultures of cells from which mitotic cells had been removed by 
mitotic shake off. After 2 h, blocked cells were harvested by mitotic shake- 
off and were subsequently replated in prewarmed complete media sup- 
plemented with the indicated drug. Stock solutions of  cytochalasin D (5 mg/ 
ml) and colchicine (1 mM) were prepared in DMSO and ethanol (100%), 
respectively. 
Electrophoresis and Immunoblotting 
Cells were harvested by centrifugation after scraping the culture dish (if 
necessary). The cell pellets were then rinsed twice in cold (4°C) PBS and 
lysed by the addition of SDS solubilization solution (50 mM Tris-HCl, pH 
7.5, 5 mM EDTA, 1% SDS). The extracts were then placed in a boiling wa- 
ter bath for 5 rnin, briefly sonicated, and centrifuged to remove the residual 
insoluble material. The supernatants were removed and stored at  -80°C. 
Protein concentrations were determined by the bicinchonic acid method 
using bovine albumin as the standard (Smith et al.,  1985).  Before elec- 
trophoresis, extracts were diluted with 3x  SDS-sample buffer (150  mM 
Tris-HC1,  pH 6.8, 10% ~-mercaptoethanol, 20%  glycerol, 3%  SDS) and 
boiled for ,'~2 min. 
SDS-PAGE was carded out according to the protocol of Laemmli (1970). 
To visualize total protein content, gels were stained for 1 h with Coomassie 
brilliant blue R-250 (0.1% in 50%  methanol, 10%  acetic acid).  The gels 
were then destained in 10%  methanol, 10%  acetic acid overnight. 
For immunoblot analysis, gels were electrically transferred (Towbin et 
al.,  1979)  to polyvinyldifluoride sheets (Immobilon-P; Millipore Corp., 
Bedford, MA) for 16 h at 4°C and 150 mA. Sheets were blocked for 1 h 
in a solution of  5 % nonfat dry milk in Tris-buffered saline (10 mM Tris-HCI, 
pH 7.2, 0.9% NaCI, 0.1% Tween-20), followed by incubation in an appro- 
priate dilution of either the anti-CENP-E antiserum pAbl  (Yen  et al., 
1992), anti-cyclin B antiserum (Muschel et al., 1993), or the anti-a-tubulin 
monoclonal antibody DM1A (Blose et al.,  1984).  Immunoreactive bands 
were visualized with 125I-conjugated-protein  A followed by autoradiogra- 
phy on film (XAR; Eastman Kodak, Rochester, NY) for 8-24 h at -80°C 
with intensifying screens. 
Metabolic Labeling and lmmunoprecipitation 
To measure the CENP-E synthetic rate during the cell cycle, K562 cells at 
various phases of the cell cycle were obtained by centrifugal elutriation. An 
aliquot containing a  total of 2.5  ×  105 cells at the indicated cell cycle 
phase was removed, washed twice in prewarmed, methionine-free RPMI 
1640 (Gibco Laboratories, Grand Island, NY), and incubated in 0.5 ml of 
the same medium for 30 rain at 37°C. The cells were then pelleted and 
resuspended in 0.5 ml of medium, and 1 mCi of 35S-TransLabel (ICN (Ir- 
vine, CA)) was added to each aliquot. After an additional 30-rain incuba- 
tion, the cells were washed three times in cold (4°C) PBS, and cell extracts 
prepared as outlined below. 
For pulse-chase experiments, cells in the G1 phase of the cell cycle were 
obtained by elutriation and cells synchronized at the G1-S border were ob- 
tained by double-thymidine block. Aliquots of each cell population (2.5  × 
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Label. Cells were washed twice with complete media, resuspended in the 
same, and equal cell numbers were replated into parallel dishes. At the indi- 
cated times, cells were washed with cold PBS, and extracts for immunopre- 
cipitation were prepared by incubating the washed ceils in 100 #1 of lysis 
buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCI,  1% Triton X-100, 0.5% 
Na-deoxycholate) containing protease inhibitors (10 t~g/mi E-64,  1 t~g/mi 
N-tosyl-L-phenylaianine chloromethyl ketone, 0.1/~g/mi Pepstatin, 50 t~g/ 
ml  N-tosyl-L-lysine chloromethyl ketone,  50  #g/mi antipain,  40  /~g/ml 
PMSF, 12 t~g/mi phosphoamidon, 6 #g/mi leupoptin, 6 t~g/mi aprotinin; all 
inhibitors were purchased from Boehringer-Mannheim Corp. [Indianapolis, 
IN]).  The extracts were then vortexed briefly and centrifuged (10  min/ 
14,000 rpm at 4°C) to pellet the nuclei and other insoluble material. The 
level of 3ss incorporation in each of the extracts was determined by scintil- 
lation counting of the TCA-precipitable material after alkaline hydrolysis 
(Pelham and Jackson, 1976).  For synthetic rate studies, a volume of cell ex- 
tract containing 5  ×  106 cpm was combined with 2 tzl of pAbl and lysis 
buffer (final vol 50/~1), and the tubes were placed on ice for 1 h. After this, 
25/~1 of a 50% (vol/vol) slurry of protein A-Sepharose beads (Pharmacia 
Fine Chemicals, Piscataway,  NJ) diluted in PBS was added and the tubes 
were rotated in an end-over-end fashion at 4°C for 1 h. Subsequently, the 
beads were collected by centrifugation, washed extensively in RIPA buffer 
(50 mM Tris-HCl, pH 8.0, 150 mM NaC1, 1% Triton X-100, 0.5% Na-deoxy- 
cholate, 0.1% SDS, 1 mM EDTA, 100/~M PMSF) at 4°C, and finally boiled 
in 50 #1 of SDS sample buffer.  The entirety of each sample was then sub- 
jected to SDS-PAGE, and the gels were processed for fluorography. 
RNA Analysis 
Total cellular RNA was isolated from elutriated K562 cells using guanidine 
isothiocyanate as described (Sambrook etal., 1989).  To track the presence 
of CENP-E mRNA in these samples nnclease S1 analysis was conducted 
as outlined by Yen etal. (1988).  As a probe, a CENP-E cDNA clone (clone 
liB [Yen et al.,  1992])  in BlueScript KSII was digested with Cla I and a 
3.0-kb fragment that contains 204 bp (nucleotide no. 98-302) of the CENP-E 
open reading frame was isolated. Subsequently, this DNA fragment was 
5' end-labeled with 32p, hybridized to 100/~g of RNA isolated from the 
elutriated cell fractions, and following SI digestion, the protected fragments 
were resolved on an 8% acrylamide, 7 M urea gel and visualized by autora- 
diography. Hpa II digested pBR322 fragments were used as size markers. 
Expression and Purification of CENP-E Using 
a Baculovirus Expression System 
The entirety of the CENP-E cDNA was originally isolated as seven overlap- 
ping cDNA clones (Yen etal., 1992).  Subsequently, a full-length CENP-E 
cDNA clone was constructed using convenient internal restriction sites. Af- 
ter the creation this clone in BlueScript KS II cloning vector (Stratagene, 
La Jolla,  CA), the full-leagth CENP-E cDNA was cloned as an 8.3-kb 
BamHI-SalI fragment into the baculovirus recombination/expression  vector 
pVL 1393  (Invitrogen, San Diego, CA). The resultant plasmid (pVL CE 
1-2663) was then co-transfected into St9 cells along with linearized bacu- 
lovirus genomic DNA (Baculo-Gold) according to the manufacturer's spec- 
ifications (PharMingen, San Diego, CA). Subsequently, recombinant bacu- 
lovirus was purified by serial dilution and amplified. CENP-E expression 
in Sf9 cells infected with excess virus was highest 96 h after infection. 
To obtain large quantities of recombinant CENP-E, 2  x  10  s Sf9 cells 
were infected with ,~1  x  109 pfu of recombinant baculovirus. After 96 h 
the cells were harvested by centrifugation (5 min/2,000 rpm) and washed 
extensively in PBS. The cells were then lysed by sonication in column buffer 
(50 mM Tris-HC1, pH 7.5, 5 mM EDTA, 1 mM PMSF), the insoluble mate- 
riai was removed by centrifugation (10 min/14,000 rpm at 4°C), and soluble 
lysate was then applied to a Sephrose CL-4B column (bed volume "~150 ml) 
at a flow rate of 1 mi/5 min. Column fractions were assayed for CENP-E 
content by SDS-PAGE followed by Coomassie blue staining, and the CENP- 
E-enriched fractions were pooled. The absolute quantity of CENP-E in the 
partially purified fraction was determined to be 10 #g/mi by scanning densi- 
tometry (Ultroscan XL; Pharmacia Biotech, Piscataway,  NJ) using purified 
skeletal muscle myosin as a standard. 
Qantitation of lmmunoprecipitations 
and Immunoblots 
Signals from metabolically labeled proteins and immunoblots labeled with 
t25I-protein A were quantified by phosphorimaging (Molecular Dynamics, 
Inc., Sunnyvale, CA).  For quantitative immunoblnt analysis, a  standard 
curve of signal vs amount of CENP-E was obtained by analysis of a series 
of known amounts of CENP-E immunoblotted in parallel.  For this, full- 
length CENP-E was partially purified from St9 ceils infected with recom- 
binant baculovirus as outlined above. Appropriate quantities of cell extracts 
and purified recombinant CENP-E were subjected to SDS-PAGE followed 
by electrotransfer to nitrocellulose sheets. All gels in a single assay were 
transferred in the same cassette to a single sheet of nitrocellulose to assure 
equal transfer of  the cell extracts and standards. The resultant nitrocellulose 
sheet was then processed for immunoblot analysis as outlined above. 
lmmunofluorescence Microscopy 
Nocodazole-arrested mitotic HeLa ceils were harvested by shake-off  as out- 
lined above, rinsed extensively in nocodazole-free  complete media, and was 
finally suspended in complete media supplemented with 5 #g/mi cytochala- 
sin D. After incubation for various times, the cells were harvested by cen- 
trifugation, rinsed several times with PBS, and the cell suspension was then 
applied to poly-L-lysine-coated  coverslips for 10 min at room temperature. 
Subsequently, the coverslips were rinsed in PBS, and the cells were fixed 
by emersion in cold (-20°C) methanol for 5  min. The ceils were then 
incubated at 37"C sequentially with: (a) mAb 177 (1:10 dilution of culture 
supernatant), (b) biotinylated goat anti-mouse IgG (1:500  dilution; Kir- 
kegaard &  Perry Laboratories, Inc., Gaithersburg, MD),  (c)  Texas  red- 
conjugated strepavidin (1:1,000 dilution; Vector Laboratories, Burlingame, 
CA) and (d) 0.1 ftg/ml 4',6'-diamidino-2-phenyl-indole  (DAPI) 1. Cells were 
rinsed extensively in PBS between each incubation, and all reagents were di- 
luted  in  PBS/5%  bovine  serum  albumin.  Finally,  the  coverslips were 
mounted and viewed in an epifluorescence microscope (BH2;  Olympus 
Corp.,  Lake  Success,  NY)  and  images were recorded on 35-mm film 
(TMAX, 400 ASA; Eastman Kodak). 
Results 
CENP-E Accumulates Progressively  during the 
Cell Cycle 
Previous work determined that cells in G1 and early S phase 
contained little detectable CENP-E, while the levels of this 
protein rose sharply during late S and G2/M (Yen et al., 
1992).  To  demonstrate directly cell  cycle-dependent ac- 
cumulation of CENP-E,  we used centrifugal elutriation of 
cultures of the human erythroleukemia cell line K562 (Fig. 
1 A). Immunoblotting of  equal protein loadings from extracts 
of elutriated ceils that represent the breadth of the cell cycle 
revealed a progressive accumulation (Fig. 1, B and C). Phos- 
phorimaging revealed a 10-fold increase in CENP-E level per 
cell between G1 and G2/M. This represents a minimum esti- 
mate of the magnitude of the change in CENP-E abundance 
across the cycle, since currently available methods do not al- 
low for the isolation of cell populations synchronized at the 
very beginning of G1 and the very end of G2. 
To determine the mechanism responsible for CENP-E ac- 
cumulation, the synthetic rate of CENP-E was measured by 
immunoprecipitation after pulse labeling of K562 cells with 
[35S]methionine/cysteine. Immunoprecipitation using a poly- 
clonal antibody (pAbl)  to a  bacterially expressed portion 
of the CENP-E rod revealed that a  single high molecular 
weight protein was specifically precipitated (Fig. 2 A, lanes 
1  and 2).  This  protein  was  unambiguously identified as 
CENP-E, not only because of its expected size, but also be- 
cause  its  precipitation  was  blocked by  competition with 
purified CENP-E  (expressed by recombinant baculovirus, 
see Fig. 4 B). CENP-E was quantitatively immunoprecipi- 
tated under these conditions, since addition of 10-fold as 
1. Abbreviation  used in this paper: DAPI, 4',6'-diamidino-2-phenyl-indole. 
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the cell cycle (Fig. 2 B), although phosphorimaging further 
showed that CENP-E synthetic rate in S and G2 was approxi- 
mately twofold that in G1. Mechanistically, this modest in- 
crease in synthesis during the later stages of interphase cor- 
responds to an increased mRNA content rather than a change 
in translation efficiency,  since S1  nuclease analysis deter- 
mined that the CENP-E mRNA level also increases approxi- 
mately threefold from G1 to G2/M (Fig. 2  C). 
To assess whether changes in protein stability contribute 
to  cell-cycle dependent  accumulation  of CENP-E,  K562 
cells were metabolically labeled in G1 and chased for a total 
of 8.5 h (at which point "030%  of the cells had transitioned 
into  S  phase  [data  not shown]).  Immunoprecipitation of 
CENP-E revealed a gradual loss (Fig. 3 A), corresponding 
to t~/: during G1  of "06 h  (Fig.  3  C). After pulse labeling 
of cells synchronized at the G1/S boundary (using double 
thymidine block), no diminution of CENP-E signal was ob- 
served during the entirety of  the subsequent S and G2 phases 
(Fig. 3, B and C). Since we believe a 25 % reduction (a loss 
that would require a half-life of 14 h for the combined 8 h 
S and G2 phases) would have been detectable, this estab- 
lishes that CENP-E is stabilized to a cytoplasmic half-life of 
>114 h during late interphase. 
Figure 1. CENP-E accumulates  progressively  during the cell cycle. 
(A) Cytofluorographic  analysis  of K562 cells in exponential  growth 
phase (Log) and elutriated cell fractions 1-6 (abcissa, DNA con- 
tent; ordinate, nucleii content). (B) Extracts were made from the 
elutriated cell fractions 1-6, and equal protein loadings (50 #g/lane) 
from each fraction were subjected  to immunoblot analysis with the 
anti-CENP-E  antisera pAbl (arrow, CENP-E). (C)  Coomassie 
blue-stained gel of elutriated cell fractions to assure equal protein 
loadings. (Migration  of molecular  mass markers in kD is indicated.) 
much cell extract yielded a proportionate increase in CENP-E 
precipitated, and immunoblot analysis of the supernatants 
revealed no detectable CENP-E in these fractions (data not 
shown).  Immunoprecipitation after pulse-labeling of cells 
isolated by elutriation at various points in the cell cycle re- 
CENP-E Undergoes Striking Loss after 
the Onset of  Metaphase through a 
Cytokinesis-independent Mechanism 
An initial qualitative pulse-chase experiment previously de- 
termined that CENP-E  is  lost as cells transition from M 
phase to G1 (Yen et al.,  1992).  To examine the mechanism 
responsible for this selective loss of CENP-E at the termina- 
tion of  mitosis, nearly pure populations of  mitotic HeLa cells 
were collected via mitotic shake-off. Extracts were prepared 
immediately from some of these M phase cells. Addition- 
ally, extracts were made from others only after replating and 
incubation for 3 h, by which time virtually all of the cells 
had completed mitosis and had entered interphase.  When 
these extracts were analyzed for CENP-E by immunoblot- 
ting, a strong signal for CENP-E was evident in the M phase 
extract made from 5  x  104 cells (Fig. 4 A, lane 1 ), but no 
CENP-E  was detected in the extract made from an equal 
number of early G1 cells (Fig. 4 A, lane 2). To quantitatively 
measure the CENP-E content of cells in M phase vs G1, we 
isolated full-length CENP-E by using a baculovirus expres- 
sion system (Fig. 4 B) and partially purifying CENP-E by 
gel  filtration chromatography (Fig.  4  B,  lanes 4  and 5). 
CENP-E levels  in M  and G1  extracts were determined by 
phosphorimaging using quantitation standards provided by 
a dilution series of this recombinant CENP-E immunoblot- 
ted in parallel. This revealed M phase and G1 cell popula- 
tions to contain 11.9 (+2.3) and 1.3 (+0.33) fg/cell, respec- 
tively, of CENP-E. By using the predicted molecular weight 
of CENP-E  (312,000  Ds),  this  corresponds  to  "022,000 
CENP-E  molecules/mitotic HeLa cell and  ,02,400  mole- 
cules/cell in G1 (Fig. 4 C). Hence, when assessed on a per 
cell basis, CENP-E undergoes an "010-fold loss between M 
phase and early G1  cell populations, a  loss quantitatively 
similar to the 16-fold diminution measured for cyclin B in 
a parallel analysis of the same samples (not shown). 
In an earlier report, CENP-E was shown to be restricted 
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ally  synthesized  during  the 
cell cycle. (.4) Immunoprecip- 
itation assays from metaboli- 
caUy  labeled  K562  cell  ex- 
tracts  were conducted  in the 
absence (lane 1 ) and presence 
of  pAbl  (lane  2)  and  both 
pAbl  and  purified  recom- 
binant CENP-E (50 rig) (lane 
3)  followed  by  SDS-PAGE 
and fluorography. Note that a 
single high molecular  weight 
protein  (arrow)  was  spe- 
cifically  precipitated  with 
pAbl, and that the precipita- 
tion of  this protein was ablated 
by the addition of competitor. 
(B)  Elutriated  K562  cells  at 
the indicated points in the cell 
cycle  were  metabolically  la- 
beled and CENP-E  immuno- 
precipitated  from equal cpm from these extracts  (2  x  10  ~) with pAbl.  (Upper panel) Autoradiogram  of precipitated  material,  arrow 
marks presence of CENP-E; the relative abundance of the immunoprecipitated CENP-E in each fraction is noted. (Lower  panel) 3  x  104 
cpm from each of  the extracts were assayed to assure that equal counts from each of  the extracts were assayed. (C) Total RNA from elutriated 
K562 ceils (100/~g/fraction)  was subjected to S1 analysis to assess CENP-E mRNA levels. (Upper panel) Autoradiogram  of protected 
fragments (arrow); the relative abundance of the 204 nucleotide (nt) protected  fragment in each fraction is noted.  (Lower panel) Total 
RNA from each of the cell fractions (2.5 t~g/lane) was subjected to agarose gel electrophoresis followed by staining with ethidium bromide 
to assure equality of RNA assayed per fraction.  The migration of the 28S and  18S rRNAs are indicated. 
to the midbody during the later stages of mitosis (Yen et al., 
1991).  This observation, when combined with the finding 
that in the human cell line D-98S the midbody is discarded 
at the conclusion of cytokinesis (Mullins and Biesele, 1973, 
1977), led to a working hypothesis that CENP-E sequestra- 
tion to the midbody and subsequent loss of this structure rep- 
resented the underlying mechanism responsible for CENP-E 
loss during the transition from mitosis to interphase. Since 
this proposed mechanism of loss requires  cytokinesis, we 
tested it directly by comparing CENP-E levels in cells tran- 
siting  from M  to G1  in  the  presence or absence of cyto- 
kinesis. This was possible, since actin-disrupting cytochala- 
sins have been shown to inhibit cytokinesis (Carter,  1967; 
Schroeder,  1970)  without affecting cell cycle advance. 
In  an  initial  experiment,  HeLa  cells  were  blocked  at 
prometaphase  using  the  reversible  microtubule  inhibitor 
nocodazole, the nocodazole was removed, and the mitotic 
cells were replated in the presence or absence of 5/~g/ml 
cytochalasin D. Immunofluorescence microscopy confirmed 
that, as expected, the cells were arrested in a prometaphase- 
like state with condensed chromatin and CENP-E (visual- 
ized with the anti-CENP-E monocl.onal antibody mAb 177 
[Yen et al., 1991]) localized as discrete dots within the chro- 
matin mass (Fig. 5 A). Within 1 h after the simultaneous re- 
lease of the nocodazole block and addition of cytochalasin 
D, the majority of the cells had chromosomes aligned along 
the metaphase plate (metaphase cells) or chromosomes in 
the  process  of translocation  towards opposite poles  (ana- 
phase cells) (Fig. 5, B and C, respectively). Metaphase cells 
revealed CENP-E  immunoreactivity as distinct  dots  colo- 
calized with the chromosomes (Fig. 5 B), whereas by ana- 
phase CENP-E had relocalized to the  interzonal  microtu- 
bules of the spindle (Fig. 5 C). Within 2 h after removal of 
the nocodazole arrest, the majority of cells cultured in the 
absence of cytochalasin D had completed cell division (data 
not shown). At the same time point, an equal proportion of 
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Figure  3.  Stability  of the  CENP-E  polypeptide 
during  the  cell  cycle.  Pulse-chase  analysis  on 
K562 cells at the indicated points in the cell cycle 
was conducted.  Subsequently, extracts were pre- 
pared and immunoprecipitation  of CENP-E,  fol- 
lowed by SDS-PAGE and fluorography, was per- 
formed.  (A)  Pulse-chase  analysis  of K562  cells 
isolated in the (31 phase of  the cell cycle by elutria- 
tion.  (B) Pulse-chase analysis of K562 cells syn- 
chronized  at  the  G1/S border  by  a  double- 
thymidine block (arrow, CENP-E). (C) Graphical 
depiction of the measured  CENP-E signal values 
obtained  from two pulse-chase  experiments. 
Brown et al. CENP-E  Accumulation and Loss during the Cell Cycle  1307 Figure 4. CENP-E undergoes 
a quantitative 10-fold loss as 
cells transition from mitosis 
to interphase. (A) Extracts of 
mitotic HeLa cells  (lane 1) 
and cells that have completed 
mitosis  and  reentered inter- 
phase (lane 2) were analyzed. 
(Upper panel) Extracts pre- 
pared from 5  x  104 cells of 
each  population  were sub- 
jected to immunoblot  analysis 
with pAbl, CENP-E is noted 
(arrow). (Lower  panel) Coo- 
massie  blue-stained  gel  of 
equal  cell  numbers of each 
cell population. (B) Extracts 
(50/,g/lane)  from uninfected 
Sf9 cells (lane 1),  cells  in- 
fected with wild type (lane 2), 
and recombinant baculovirus expressing the full-length CENP-E molecule (lane 3), as well as a preparation of purified recombinant 
CENP-E (lane 4, 10 gg), were subjected to SDS-PAGE followed  by Coomassie blue staining. (Lane 5) Immunoblot of purified CENP-E 
fraction (500 ng) with pAbl. Migration of expressed CENP-E is noted (arrow). (C) CENP-E content in M and G1 extracts was measured 
by quantitative immunoblotting  as outlined in Materials and Methods. Shown is a graphical depiction of the calculated values for CENP-E 
molecules/cell in M and G1. 
cells cultured in the presence of cytochalasin D progressed 
into G1 but without undergoing cytokinesis, as demonstrated 
by the presence of two well-formed nuclei with decondensed 
chrornatin contained within the borders of a single cell (Fig. 
5, D and E). Staining of these ceils with lamin antisera con- 
firmed the reassembly of a nuclear lamina in each nucleus 
(data not shown). Despite the inhibition of cell division, in- 
direct immunofluorescence  failed to detect CENP-E in binu- 
cleate cells (Fig. 5, D and E, arrowed cells), although it was 
readily observable in the few cells still in mitosis (Fig. 5 E, 
arrowhead). As these observations correlate exactly with the 
previously determined localization of CENP-E in non-drug 
treated cells (Yen et al., 1991) and nocodazole-arrested cells 
released from the drug but replated in the absence of cyto- 
chalasin D  (data not shown),  we conclude that the cyto- 
chalasin  D-dependent  inhibition of cytokinesis does  not 
affect the localization of CENP-E during mitotic progres- 
sion. However, the subsequent apparent loss of CENP-E in 
cells that have completed mitosis without undergoing cyto- 
kinesis is inconsistent with CENP-E loss requiring CENP-E 
sequestration to and loss with the midbody. 
To  prove  directly  that  the  diminished  fluorescence  of 
CENP-E as cells progress from M  to G1  reflected actual 
polypeptide loss in the absence of cytokinesis, extracts were 
prepared  from  cells  at  various  times  after  release  from 
nocodazole  arrest.  Immunoblotting revealed  clearly  that 
most CENP-E was lost during a 2-h period after release from 
the nocodazole block, regardless of whether cytochalasin D 
was present (Fig. 6, A and B, top panels).  CENP-E loss mir- 
rored that seen for cyclin B (Fig. 6, A and B, middle panels), 
whose  degradation  during  mitotic  progression  in  inver- 
tebrate oocyte systems is known not to require cytokinesis 
(e.g., Standart et al., 1987; Hunt et al., 1992). Also like cy- 
clin B, loss of CENP-E requires postprometaphase mitotic 
progression (Fig. 6 C, top and middle panels),  since in mi- 
totically arrested cells replated in the presence of colchicine, 
both CENpoE and cyclin B levels remained unchanged over 
a subsequent 2-h period. Additionally, immunoblot analysis 
of these extracts with an antitubulin antibody revealed that 
the tubulin levels remain constant in all extracts, confirming 
the uniformity of the protein loadings and the absence of 
generalized proteolysis (Fig. 6, A-C, bottom panels). 
To  determine  whether  CENP-E  degradation  coincides 
temporally with destruction of cyclin B, CENP-E and cyclin 
B levels were quantified during mitotic progression after re- 
lease from nocodazole-induced prometaphase arrest (Fig. 
7). This revealed that ,'~60 % of  the cyclin B was lost 1 h after 
the release of the nocodazole block,  and that degradation 
continued steadily during a 2-h time period. While CENP-E 
undergoes a comparable degree of loss during the same time 
period, loss of this polypeptide initiates only after a 1-h lag. 
Overall,  we  conclude  that  CENP-E  is  selectively lost 
through a degradative pathway that initiates in late anaphase/ 
telophase. 
Discussion 
To earlier identification of CENP-E to be the only ldnesin- 
like, putative microtubule-dependent motor presently known 
to associate with kinetochores during mitotic chromosome 
movements, we have now shown that CENP-E is also one of 
only a handful of mammalian proteins whose accumulation 
and loss is known to be coupled to cell cycle progression. 
Further, although a modest increase in CENP-E synthesis is 
seen between G1 and G2, we have found in both interphase 
and mitosis that accumulation and loss  results primarily 
from changes in the rate of  CENP-E degradation, rather than 
the rate of synthesis. Moderately unstable during G1 (tv2 of 
,~6 h), CENP-E is completely stabilized during S/G2 and the 
stages of  mitosis through metaphase. However, after the ana- 
phase transition, CENP-E is destined for inactivation at the 
terminal phases of mitosis through parallel pathways that 
The Journal  of Cell Biology,  Volume 125, 1994  1308 Figure 5. Cytochalasin  D treatment of mitotic HeLa cells blocks cytokinesis but exerts no effect on CENP-E localization during mitotic 
progession.  Mitotically arrested HeLa cells (nocodazole block) were collected and replated in the presence of cytochalasin D (5/zg/ml). 
At the indicated times, cells were fixed and stained with DAPI to visualize DNA and with mAb 177 to visualize CENP-E.  (A) O h after 
release from nocodazole, (B) Cell in metaphase 1 h after release from nocodazole. (C) Cell in anaphase 1 h after release from nocodazole. 
(D and E) Cells 2 h after release from block.  (Arrows, nuclei present within bi-nucleate cells; arrowhead, cell in anaphase).  Scale bar, 
5/~m, A and C;  10 #m,/~ and E. 
sequester it to the developing midbody and selectively de- 
grade it. 
Combining the measured synthetic rates in G1  vs S and 
G2, the pseudo-first-order decay during G1, and the rapid 
degradation of almost all CENP-E at the later stages of M 
yields the pattern for CENP-E accumulation shown in Fig. 
8  A.  CENP-E accumulates primarily in  G2 as a  result of 
selective stabilization  and a  modest increase in  synthesis. 
CENP-E polypeptide accumulation and loss is reminiscent 
of that initially described for cyclins A and B, proteins first 
Brown et al.  CENP-E Accumulation and Loss during the Cell Cycle  1309 Figure 6. The inhibition of cytokinesis with cytochalasin D exerts 
no effect  on the loss of CENP-E during mitotic progression. HeLa 
cells blocked in mitosis with nocodezole were collected by mitotic 
shake-off. (A) Cells replated in the absence of cytochalasin D 
(DMSO was added to 0.1%). (B) Cells replated in the presence of 
cytochalasin D (5/~g/ml). (C) Cells replated in the presence of  col- 
chicine (1/zM). Extracts from treated cells were prepared at the in- 
dicated time points, and immunoblot  analysis for the indicated  pro- 
teins was performed. All lanes probed for CENP-E loaded at 35/~g 
total protein/lane, 50  /~g/lane for cyclin B,  and  10 /zg/lane for 
mbulin. 
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Figure 7. Kinetics of CENP-E and cyclin B loss after release from 
nocodazole.  Mitotically blocked (nocodazole)  HeLa cells were col- 
lected by mitotic shake and replated in the absence of  the drug. Ex- 
tracts were formed at the indicated time points and quantitative  im- 
munoblot analysis was performed.  Graphical representation of 
measured immunoblot signals is displayed. 
discovered as a consequence of their oscillatory accumula- 
tion and destruction in invertebrate oocytes after fertilization 
(Evans et al.,  1983;  Swenson et al.,  1986;  Standart et al., 
1987).  The cyclins are continuously synthesized between 
cell divisions and are rapidly degraded near the end of mito- 
sis in invertebrate embryos (Evans et al., 1983; Swenson et 
al.,  1986;  Standart et al.,  1987).  In human cells, cyclin B 
accumulates sharply in G2 (an increase arising from a four- 
fold elevation in cyclin mRNA levels), peaks in early M, and 
then plummets in abundance by the end of cell division 
(Pines and Hunter, 1989). Although the G2 increase in cyclin 
B relies more heavily on increased mRNA abundance, the 
pattern of accumulation of both CENP-E and cyclin B are 
similar overall, accumulatins primarily in G2 and rapidly 
degraded during the later portion of M phase. 
The degradation of CENP-E, combined with three earlier 
examples (cyclin A, cyclin B, and as yet unidentified  compo- 
nent(s) degraded at the metaphaseJanaphase transition; see 
below) defines a cascade of  at least four temporally regulated 
proteolytic steps during mitosis (outlined schematically in 
Fig. 8 B), The earliest of these is degradation of cyclin A, 
whose loss clearly precedes degradation of cyclin B both in 
embryonic systems (MinshuU et al., 1989b,  1990; Luca and 
Ruderman, 1989; Lehner and O'Farrell, 1990; Hunt et al., 
1992)  and human cells  (Pines and Hunter,  1990).  Since 
degradation of cyclin A but not cyclin B proceeds normally 
in mitotic cells treated with microtubule disrupting agents 
(Minshull et al.,  1989b;  Hunt et al.,  1992;  Edgar et al., 
1994),  and cyclin B but not cyclin A  can be detected in 
metaphase cells of early Drosophila  embryos (Lelmer and 
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Figure 8. Kinetics of CENP-E 
accumulation across the cell 
cycle and  timing  of degra- 
clarion  during  mitosis.  (A) 
CENP-E accumulation  during 
the cell cycle  calculated from 
measured synthetic  and degra- 
dation rates. (B) The morpho- 
logical stages  of  mitosis are il- 
lustrated  along  with  the 
established sequence and tim- 
ing of the degradation of cy- 
clin A, cyclin  ]3, and CENP-E 
during  mitotic  progression. 
The  proteolytic  substrate(s) 
whose  degradation  tris~rs 
the  metaphase to  anaphase 
transition is denoted as Fac- 
tor(s) X. 
The Journal  of Cell Biology,  Volume 125, 1994  1310 O'Farrell,  1990),  cyclin  A  must  be  degraded  before  the 
metaphase/anaphase transition. In contrast, (and contrary to 
a widely accepted view, e.g., Murray and Kirschner, 1989a), 
it  is now clear that  cyclin B  degradation  occurs after the 
metaphase to anaphase transition.  This was initially shown 
by Surana et al.  (1993), who showed that at the restrictive 
temperature,  Saccharomyces  cervisiae, which  harbor  a 
temperature-sensitive cdc15, progress into mitosis and sub- 
sequently  arrest  in  late  anaphase/telophase,  but with  un- 
diminished cyclin B levels. This finding was confirmed and 
extended using frog egg extracts that can be manipulated to 
complete the cell cycle in vitro, including assembly of mi- 
totic spindles, anaphase chromosome segregation, andxefor- 
marion  of normal  interphase  nuclei.  With  this  approach, 
Holloway et al.  (1993) showed that anaphase chromosome 
movement can occur without cyclin B degradation or dimi- 
nution of p34  cDc2 activity. Despite this, anaphase movement 
was blocked by addition of inhibitors of ubiquitin-mediated 
proteolysis. Taken together, these findings indicate that cy- 
clin  B  degradation  is  not  the  trigger  for  initiation i of 
anaphase, and that ubiquitin-dependent proteolysis of a sub- 
strate(s) other than cyclin B is required for the execution of 
the metaphase to anaphase transition.  It remains unclear if 
cyclin B degradation occurs contemporaneously with the be- 
ginning of anaphase ~or at a later point in mitotic progression. 
As we have shown here, CENP-E degradation represents a 
further proteolytic step that initiates after cyclin B. 
While only a handful of other proteins are known to un- 
dergo cell cycle-dependent accumulation, there may be fur- 
ther proteolytic steps yet to be uncovered. One obvious ex- 
ample is thymidine kinase,  which is reduced in abundance 
by  15-fold at the terminal  phases  of mitosis  (Sherley and 
Kelly, 1988), although the exact timing of degradation is un- 
known.  Changes in abundance have also been reported for 
two other chromosomal proteins, topoisomerase II (Heck et 
al., 1988) and the INCENPs, a family of proteins that lie be- 
tween sister chromatids at metaphase, lose their association 
with chromosomes just before or just after sister chromatid 
separation,  and  ultimately  associate  with  the  midbody 
(Cooke  et  al.,  1987).  For  topoisomerase  II,  abundance 
changes  only  modestly  (,o50%  diminution;  Heck et  al., 
1988), but the INCENPs mirror the behavior of CENP-E in 
that they accumulate during S/G2 and are apparently lost by 
sequestration  to  the  developing  midbody  (Cooke  et  al., 
1987).  It  is  not  yet  known  whether,  like  CENP-E,  the 
INCENPs are also degraded. 
As to the mechanism(s) mediating the events of this pro- 
teolytic  cascade,  ubiquitin-mediated  proteolysis  has  been 
shown to be responsible for the degradation  of the cyclins 
(Glotzer et al.,  1991;  Hershko et al.,  1991).  It should also 
be noted that active cyclin B/p34  cDc2 complexes are neces- 
sary to activate the cyclin destruction pathway(s) (Luca et 
al.,  1991).  Since  CENP-E  contains  a  sequence  (967RNA- 
LESLKQ975) highly  similar to the RAALAVLKS "destruc- 
tion box" proposed to mediate the ubiquitin-dependent pro- 
teolysis of human cyclin A  (Glotzer et al.,  1991),  it seems 
plausible that CENP-E degradation may also be mediated by 
a  ubiquitin-dependent  mechanism.  Alternatively,  CENP-E 
contains  two regions  (residues  459-489  and  2480-2488) 
with  strong  homology  to  PEST  sequences  (PEST-FIND 
scores of 5.8  and  1.7, respectively  [Rogers et al.,  1986]). 
Since PEST sequences, which are rich in proline (P), glu- 
tamic acid (E), serine (S), and threonine (T) residues, have 
been shown to be responsible for the rapid intracellular deg- 
radation of a variety of proteins (Rogers et al.,  1986; Rech- 
steiner,  1990), CENP-E degradation may be mediated through 
such motifs. 
Whatever the mechanism(s) of degradation of proteins are 
at each step of the cascade, it is clear that a series of timed 
proteolytic steps are key events during mitotic progression. 
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